New York Oncology Hematology (NYOH), an area provider of medical oncology, hematology and radiation oncology, just opened a state-of-the-art $20 million dollar cancer treatment center designed to help meet the needs of cancer patients living in and near Saratoga County.
With last week’s ribbon cutting, residents of the Clifton Park area now have access to top-notch, out-patient cancer care in a 28,000-square-foot facility behind The Crossing Plaza.
The Clifton Park center marks NYOH’s seventh location, replacing their Latham location and joining their other locations in Albany, Albany Medical Center, Amsterdam, Hudson, Rexford and Troy. Collectively, NYOH physicians see more than 100,000 cancer visits annually.
These out-patient facilities help bring cancer care closer to home in a more intimate setting than seeking treatment at a hospital. At the ribbon cutting, many patients spoke very highly of the care received at New York Oncology Hematology. Erin Davidson told CNWeekly, “I’m a regular mom….I go grocery shopping, help with homework, and iron lots of polo shirts. Cancer patients are a very special cross section of our society. It’s not a regular visit to the doctor for us. We’re scared. The people at NYOH get that.”
The Clifton Park treatment center includes the region’s first Varian TrueBeam Radiotherapy System, offering area patients an advanced radiation treatment that would have previously required travel to New York City. NYOH states that the Varian TrueBeam provides pinpoint precision, enhancing physicians” ability to treat challenging cancers more precisely and reducing side effects, even in tough to treat cancers, including breast, neck, head, and abdomen.
Along with this large, high-tech piece of equipment, the center also provides a convenient, separate radiation entrance, making it easier for patients with a daily treatment regimen to get in and out of treatment quickly.
NYOH’s Clifton Park center also includes a 30-person chemotherapy infusion suite, PET and CT imaging, in-office dispensing of cancer drugs, access to national clinical research trials and hereditary risk assessment.
The new facility is located at 3 Crossing Boulevard, near the intersection with Sitterly Road, in Clifton Park NY.